Company intelligence / Profile preview

Damona Pharmaceuticals

Toronto, Ontario, Canadadamonapharma.com ↗
Ownership
Private
Development stage
Phase 1
01

Overview

Preclinical data show that DPX‑101 reverses cognitive deficits induced by amyloid deposition in Alzheimer’s models and improves cognitive performance. The FDA has cleared an IND for Phase I trials to assess safety/tolerability. The company claims potential disease-modifying effects—restoring lost neuronal connections rather than just slowing decline.

Therapeutic areas
PsychiatryNeurology
Modalities
small molecules
Industry
Biotech
02

Drug pipeline

3 assets

DPX-102

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Centre for Addiction and Mental Health (CAMH) – scientific founding/collaboration/licensing partnerOntario Brain Institute – investor/supporterUWM Research Foundation Inc., University of Tours, University of Belgrade-Faculty of Pharmacy – licensors/academic partners for lead compound AC‑101/DPX‑101 development/licensing agreements.

Beyond the preview

Go deeper on Damona Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damona Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call